Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur UPHLM0060O
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9788847021709_new
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds. 212 pp. Englisch. N° de réf. du vendeur 9788847021709
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Describes a new approach to tumor therapy based on more selective, less cytotoxic endocrine derived compoundsDescribes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inh. N° de réf. du vendeur 5810794
Quantité disponible : Plus de 20 disponibles
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance | From Basic to Clinical Research | E. E. Müller | Taschenbuch | xii | Englisch | 2012 | Springer | EAN 9788847021709 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. N° de réf. du vendeur 106117397
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -LHRH/Somatostatin.- Chapter1 Twenty-five Years of Endocrine Oncology with Analogs of Hypothalamic Peptides: an Overview.- Chapter2 Analogs of Luteinizing Hormone-releasing Hormone in Benign Prostatic Hyperplasia and Advanced Renal Cell Carcinoma.- Chapter3 Luteinizing Hormone-releasing Hormone Antagonists in Gynecology.- Chapter4 Physiology and Pharmacology of Somatostatin and Its Receptors.- Chapter5 Investigation of LHRH Receptor Involvement in Melanoma Growth and Progression.- Somatostatin/GHRH/GH.- Chapter6 Cortistatin: Not Simply a Natural Somatostatin Analogue.- Chapter7 Antineoplastic and Antiangiogenic Actions of Somatostatin Analogs.- Chapter8 Somatostatin in Clinical Endocrinology.- Chapter9 Antagonists of Growth Hormone-releasing Hormone in Oncology.- Chapter10 GH Receptor Antagonists: Basic Knowledge and Clinical Perspectives.- Ghrelin and Ghrelin Mimetics (GHS).- Chapter11 Hypothalamic Circuits Responsive to Ghrelin: Regulation by Leptin and Insulin.- Chapter12 Physiological Function of Growth Hormone Secretagogue Receptors in the Cardiovascular System.- Chapter13 Endocrine and Extraendocrine Activity of Ghrelin and the GHS: Basic Research.- Chapter14 Endocrine and Nonendocrine Actions of Ghrelin and GHS: State of the Art in Clinical Research.- Hormonal Treatments for Endocrine-Dependent Tumors.- Chapter15 Hormonal Treatments of Endocrine-Dependent Tumors: Preclinical Aspects.- Chapter16 Hormonal Treatment of Endocrine-Dependent Tumors: Clinical Considerations.- Chapter17 Letrozole in the Treatment of Advanced Breast Cancer.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 212 pp. Englisch. N° de réf. du vendeur 9788847021709
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds. N° de réf. du vendeur 9788847021709
Quantité disponible : 1 disponible(s)